Exponent, Inc. (EXPO) Key Metrics

NASDAQ: EXPOValuation, returns, debt and efficiency ratios over 10 years.

EXPO valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$3.42B
Enterprise value
$3.13B
P/E (TTM)
32.2
10-yr median 50.3
Forward P/E
31.5
PEG ratio
2.03
Price / sales
6.0
10-yr median 10.3
Price / book
10.8
10-yr median 12.8
EV / EBITDA
23.6
10-yr median 36.8
Dividend yield
1.71%
$1.23 a year
Beta
0.70

EXPO key metrics, 2020–2025

Fiscal year ended December 31, 2025 · U.S. dollars

EXPO valuation Price multiples at each fiscal year-end price.

P/E ratio−20.3%
33.6
2025 · hover or tap a bar for each year
2020: 58.2 (+29.0%)2021: 53.3 (−8.3%)2021: 61.5 (+15.3%)2022: 50.1 (−18.6%)2022: 50.6 (+1.1%)2023: 52.4 (+3.5%)2023: 45.3 (−13.5%)2024: 45.4 (+0.2%)2024: 42.2 (−7.1%)2025: 33.6 (−20.3%)
20202025
Price / sales−25.7%
6.1
2025 · hover or tap a bar for each year
2020: 12.0 (+34.7%)2021: 11.0 (−8.3%)2021: 13.4 (+21.3%)2022: 10.9 (−18.6%)2022: 10.1 (−7.1%)2023: 10.4 (+3.5%)2023: 8.5 (−18.9%)2024: 8.5 (+0.2%)2024: 8.2 (−3.0%)2025: 6.1 (−25.7%)
20202025
Price / book−16.4%
9.1
2025 · hover or tap a bar for each year
2020: 13.3 (+25.1%)2021: 12.2 (−8.3%)2021: 14.9 (+22.5%)2022: 12.1 (−18.6%)2022: 16.2 (+33.0%)2023: 16.7 (+3.5%)2023: 12.8 (−23.6%)2024: 12.8 (+0.2%)2024: 10.9 (−14.7%)2025: 9.1 (−16.4%)
20202025
EV / EBITDA−22.7%
21.7
2025 · hover or tap a bar for each year
2020: 50.8 (+33.0%)2021: 50.2 (−1.1%)2021: 51.5 (+2.5%)2022: 43.9 (−14.7%)2022: 34.1 (−22.4%)2023: 37.0 (+8.8%)2023: 30.3 (−18.2%)2024: 36.6 (+20.7%)2024: 28.1 (−23.1%)2025: 21.7 (−22.7%)
20202025
Price / free cash flow−12.9%
29.1
2025 · hover or tap a bar for each year
2020: 48.8 (+11.6%)2021: 52.92022: 63.42023: 41.02024: 33.42025: 29.1 (−12.9%)
20202025
Free cash flow yield+0.4 pts
3.4%
2025 · hover or tap a bar for each year
2020: 2.0% (−0.2 pts)2021: 1.9%2022: 1.6%2023: 2.4%2024: 3.0%2025: 3.4% (+0.4 pts)
20202025

EXPO valuation history

Fiscal year-endToday10-year median

EXPO returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

EXPO debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

EXPO cash returned to shareholders

DividendsBuybacksFree cash flow

EXPO price vs earnings per share

Share price at year-endEPS (right axis)

EXPO key metrics

2020–2025
Exponent, Inc. key metrics by fiscal year
2025202420242023202320222022202120212020
Valuation
Market capitalization$3.56B$4.59B$4.55B$4.55B$5.36B$5.18B$5.07B$6.23B$4.40B$4.80B
Enterprise value$3.42B$4.42B$4.39B$4.39B$5.22B$5.04B$4.78B$5.94B$4.18B$4.58B
P/E ratio33.642.245.445.352.450.650.161.553.358.2
Price / sales6.18.28.58.510.410.110.913.411.012.0
Price / book9.110.912.812.816.716.212.114.912.213.3
Price / free cash flow29.133.4—41.0—63.4—52.9—48.8
Price / operating cash flow27.031.8—35.7—55.2—50.0—46.5
EV / sales5.97.98.28.210.29.810.312.710.511.4
EV / EBITDA21.728.136.630.337.034.143.951.550.250.8
EV / free cash flow28.032.1—39.5—61.6—50.5—46.6
Earnings yield3.0%2.4%2.2%2.2%1.9%2.0%2.0%1.6%1.9%1.7%
Free cash flow yield3.4%3.0%—2.4%—1.6%—1.9%—2.0%
Dividend yield1.7%1.3%—1.2%—1.0%—0.7%—0.8%
Shareholder yield (dividends + buybacks)4.5%1.4%—1.7%—4.0%—0.8%—1.7%
Share price at fiscal year-end$69.46$89.10$88.19$88.04$102.54$99.09$94.98$116.73$82.58$90.03
Per share
Revenue per share$11.36$10.83$10.40$10.40$9.82$9.82$8.74$8.74$7.50$7.50
Earnings per share$2.07$2.11$1.94$1.94$1.96$1.96$1.90$1.90$1.55$1.55
Operating cash flow per share$2.57$2.80—$2.47—$1.79—$2.34—$1.94
Free cash flow per share$2.39$2.67—$2.15—$1.56—$2.21—$1.84
Cash per share$4.33$5.02$3.62$3.62$3.09$3.09$5.58$5.58$4.55$4.55
Book value per share$7.62$8.17$6.90$6.90$6.14$6.14$7.82$7.82$6.78$6.78
Tangible book value per share$7.45$8.00$6.73$6.73$5.97$5.97$7.66$7.66$6.62$6.62
Dividends per share$1.20$1.13—$1.05—$0.94—$0.81—$0.75
Capex per share$0.18$0.13—$0.32—$0.23—$0.13—$0.09
Debt per share$1.62$1.58$0.55$0.55$0.36$0.36$0.28$0.28$0.38$0.38
Shares outstanding51.2M51.6M51.6M51.6M52.3M52.3M53.3M53.3M53.3M53.3M
Change in shares outstanding−0.6%−0.1%0.0%−1.2%0.0%−2.0%0.0%+0.0%0.0%−1.0%
Returns & profitability
Return on equity (ROE)26.1%28.1%28.2%29.6%31.9%27.7%24.3%26.0%22.8%23.2%
Return on invested capital (ROIC)34.8%40.1%41.7%43.8%61.3%69.8%65.2%64.0%50.9%50.3%
Return on assets (ROA)13.4%15.1%15.3%16.3%17.4%16.1%14.8%16.0%14.1%14.3%
Return on tangible assets13.3%14.2%15.3%15.7%17.7%17.7%15.0%15.0%14.4%14.1%
Free cash flow margin21.0%24.6%—20.7%—15.9%—25.3%—24.6%
Income quality (OCF / net income)1.241.33—1.27—0.92—1.23—1.25
Financial health
Total debt$82.8M$81.5M$28.3M$28.3M$18.6M$18.6M$15.0M$15.0M$20.3M$20.3M
Cash & short-term investments$221.9M$258.9M$187.2M$187.2M$161.5M$161.5M$297.7M$297.7M$242.5M$242.5M
Net debt−$139.1M−$177.4M−$158.9M−$158.9M−$142.9M−$142.9M−$282.7M−$282.7M−$222.2M−$222.2M
Debt / equity0.210.190.080.080.060.060.040.040.060.06
Debt / assets0.100.100.040.040.030.030.020.020.040.03
Net debt / EBITDA−0.88−1.13−1.32−1.10−1.01−0.97−2.60−2.45−2.67−2.47
Current ratio2.402.742.342.342.202.202.962.963.133.13
Quick ratio2.402.742.342.342.202.202.962.963.133.13
Interest coverage————67.267.2—4.7—4.0
Working capital$249.6M$283.7M$217.6M$217.6M$190.1M$190.1M$299.8M$299.8M$249.5M$249.5M
Invested capital$251.2M$243.6M$197.2M$197.2M$177.9M$177.9M$134.3M$134.3M$139.3M$139.3M
Tangible asset value$381.7M$412.5M$347.5M$347.5M$312.1M$312.1M$408.5M$408.5M$352.9M$352.9M
Net current asset value$9.3M$90.7M$73.3M$88.8M$83.2M$83.2M$186.1M$186.1M$148.2M$134.6M
Graham number$18.83$19.71$17.36$17.36$16.44$16.44$18.27$18.27$15.37$15.37
Graham net-net per share−$1.18$0.46$0.12$0.43$0.44$0.44$2.55$2.55$2.02$1.76
Capital allocation
Dividends paid$61.5M$58.2M—$54.0M—$49.2M—$43.2M—$39.8M
Share buybacks (net)$97.1M$5.7M—$24.2M—$155.9M—$7.0M—$40.0M
Dividend payout ratio58.1%53.4%—53.9%—48.1%—42.7%—48.2%
Dividends + buybacks / free cash flow129.7%46.5%—70.5%—250.8%—42.6%—81.2%
Capex / revenue1.6%1.2%—3.0%—2.3%—1.5%—1.2%
Capex / operating cash flow7.1%4.8%—12.8%—12.8%—5.5%—4.8%
Capex / depreciation0.930.72—1.83—1.70—1.05—0.73
Stock-based compensation / revenue4.1%4.2%—3.8%—4.0%—4.1%—4.3%
SG&A / revenue4.4%4.1%64.1%4.6%56.1%56.1%62.9%62.9%65.7%65.7%
Efficiency
Days sales outstanding107.5107.4113.8114.7121.0110.2109.598.4101.8105.7
Days of inventory on hand——0.00.00.00.00.00.00.00.0
Days payables outstanding5.14.34.115.3196.4172.4155.1109.311.84.8
Cash conversion cycle (days)102.5103.1109.799.4-75.4-62.2-45.6-10.990.0101.0
Receivables turnover3.393.403.213.183.023.313.333.713.583.45
Payables turnover71.9185.2889.3323.871.862.122.353.3430.9976.68
Inventory turnover——401,004,000.00401,004,000.0035,083,000.0035,083,000.0032,594,000.0032,594,000.00303,763,000.00303,763,000.00
Asset turnover0.730.780.820.870.870.810.680.740.680.69
Average receivables$171.5M$164.4M$167.4M$168.7M$170.1M$155.0M$139.9M$125.7M$111.6M$115.9M
Average payables$6.1M$4.9M$4.5M$16.8M$18.9M$16.6M$13.8M$9.8M$9.8M$4.0M
Average inventory——$1$1$1$1$1$1$1$1
Intangibles / total assets1.1%1.1%1.3%1.3%1.5%1.5%1.3%1.3%1.5%1.4%

Computed from EXPO's annual financial statements (latest annual report filed February 27, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

EXPO valuation and financial ratios

At the end of fiscal 2025 (December 31, 2025), Exponent traded at 33.6 times earnings, against a 10-year median of 50.3. Based on the latest twelve months, the trailing P/E is 32.2 and the forward P/E is 31.5. Exponent earned a return on equity of 26.1% and a return on invested capital of 34.8% in fiscal 2025. It ended the year with $82.8 million of debt and $221.9 million in cash and short-term investments, a net cash position of $139.1 million. It returned $158.6 million to shareholders: $61.5 million in dividends and $97.1 million in share buybacks, 130% of free cash flow. The share count fell 3.9% from 53.3M to 51.2M over 9 years.

See the EXPO income statement, the EXPO chart for price history, or the EXPO stock overview for the latest quote and news.

EXPO key metrics FAQ

What is Exponent's P/E ratio?

Exponent's trailing P/E ratio is 32.2 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 31.5. At the end of fiscal 2025 it was 33.6, compared with a 10-year median of 50.3.

What is Exponent's EV/EBITDA?

Exponent's enterprise value was 21.7 times EBITDA at the end of fiscal 2025 (enterprise value $3.4 billion, EBITDA $157.4 million); the current EV/EBITDA is 23.6.

What is Exponent's return on equity?

Exponent's return on equity (ROE) was 26.1% in fiscal 2025: net income of $106.0 million on average shareholders' equity of $405.7 million.

What is Exponent's ROIC?

Exponent's return on invested capital was 34.8% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Exponent have?

Exponent had total debt of $82.8 million at the end of fiscal 2025, a debt-to-equity ratio of 0.21 and more cash than debt.

What is Exponent's dividend yield?

Exponent's forward dividend yield is 1.71%. Exponent paid $61.5 million in dividends in fiscal 2025 ($1.20 per share), a payout ratio of 58.1%.

Does Exponent buy back its shares?

Yes. Exponent spent $97.1 million on net share repurchases in fiscal 2025 Shares outstanding changed −0.6% over the year, to 51.2M..

What is Exponent's free cash flow yield?

Exponent generated $122.3 million of free cash flow in fiscal 2025, a free cash flow yield of 3.4% on its market value at year-end ($3.6 billion).

What is Exponent's current ratio?

Exponent's current ratio was 2.40 at the end of fiscal 2025: current assets were 2.40 times current liabilities.

Engineering & Construction key metrics